Prof. Ayushi Rastogi
Section Collection Information
Dear Colleagues,
The peer-reviewed open access journal has a new section called "Nano Materials and Nano Drugs" that focuses on all facets and uses of cutting-edge nanosystems. This section's major goals are to highlight and compile the most recent developments in nanomaterials and its uses in the medical, scientific, diagnostic industries. The development of nanomaterials for biomedical applications during the past two decades has shown great potential for altering the paradigm of all facets of illness treatment. Nanomaterials are particularly appealing because they can be added capabilities for early diagnostics and medication administration, making them a modularly customizable system. The emergence of nanomaterial-based platforms has the potential to lead to the development and clinical translation of new classes of biological drugs, with the possibility of precise delivery at the site of disease, or even intracellular locations, for therapeutic efficacy. Researchers now have the means to examine and work with macromolecules in real time thanks to the use of nanomaterials, and they may even be able to provide therapies at the earliest signs of disease development. Nanomaterials have played a critical role in assisting us in developing biosensors for quick diagnosis, particularly in the aftermath of the COVID-19 a pandemic. To name a few, detection techniques based on optical biosensors, electrochemical biosensors, thermal biosensors, electron activity or redox potential (amperometric/potentiometric biosensors), or changes in surface potential (ion-sensitive biosensors) have been researched. It is necessary to conduct a survey of the various classes of nanomaterials under development for applications in diagnostics and imaging, as well as for the delivery of therapeutics like small molecules and biologic drugs and prophylactic vaccines. The main obstacles that still need to be overcome from the perspective of effective delivery and mitigating toxicity concerns must also be looked into. In order to enable researchers and practitioners in nanomedicine modify their designs and formulations from a clinical perspective, a section containing resources is given. In order to speed up the development and clinical translation of these nanomaterials and so realize the full potential of nanomedicine in healthcare, significant research topics need to be highlighted.
This section's major goals are to highlight and gather recent advances in nanomaterial pharmaceuticals and their applications in pharmacological, clinical, and diagnostic domains.
Authors will benefit from a high-quality reviewing process, speedy publishing, and increased visibility due to access to a large readership.
For publishing, reviews, original research articles, communications, brief communications, comments, or technical notes will be considered.
We look forward to receiving your contributions.